Drug therapy and memory training programs: a double-blind randomized trial of general practice patients with age-associated memory impairment
Israel L, Melac M, Milinkevitch D, Dubos G · 1994 · International psychogeriatrics
What does this source report?
Three-month randomized, double-blind trial compared two piracetam groups with placebo alongside memory training. Reported benefits depended on baseline performance and training timing.
- Population and setting
- 162 adults aged 55 or older with age-associated memory impairment; 54 per arm; 135 completed
- Evidence type
- Randomized trial
- Preparation
- See the original report; formulation details require verification.
- Source language
- See linked publication
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Memory training is a co-intervention; this is not a drug-only comparison.
- 27 participants did not complete; reasons and handling require full text.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Journal article
Review depth: Abstract
Source access and review scope
Europe PMC indexed abstract checked; complete trial methods not reviewed.
Recorded source-check date: 2026-10-02. This date does not imply a completed systematic review.
Cite and trace this record
Original source: Israel L, Melac M, Milinkevitch D, Dubos G. Drug therapy and memory training programs: a double-blind randomized trial of general practice patients with age-associated memory impairment International psychogeriatrics 1994.
Molekul research summary: https://molekul.io/research/piracetam-7865703. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry